# Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain

> **NCT02173405** · PHASE1 · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 10 (actual)

## Conditions studied

- Myofascial Pain Syndromes
- Myofascial Trigger Point Pain
- Trigger Point Pain, Myofascial

## Interventions

- **DRUG:** OnabotulinumtoxinA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02173405
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08-01
- **Primary completion:** 2015-09-01
- **Final completion:** 2016-09-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-05-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02173405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02173405, "Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02173405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*